D-0090-2024 Class II Terminated

Recalled by Amneal Pharmaceuticals Of New York, LLC — Brookhaven, NY

FDA drug recall D-0090-2024 was initiated by Amneal Pharmaceuticals Of New York, LLC on Oct 27, 2023 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Aug 6, 2025). Affected quantity: 9,263 100-count bottles.

Recall details

Product Type
Drugs
Report Date
Nov 15, 2023
Initiation Date
Oct 27, 2023
Termination Date
Aug 6, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,263 100-count bottles

Product description

Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC Bridgewater, NJ, 08807, NDC# 65162-212-10

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot # HM03221A, Exp. date 12/31/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0090-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0090-2024. Report a data issue: hello@regdatalab.com.